Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
已完结
10
由 Michael 发布于 2026/8/14 9:21:58
DOI:10.1016/S0140-6736(22)00688-2
作者：B. Sands,?P. Irving,?T. Hoops,?J. Izanec,?Long-Long Gao,?C. Gasink,?A. Greenspan,?M. Allez,?S. Danese,?S. Hanauer,?V. Jairath,?T. Kuehbacher,?J. Lewis,?E. Loftus,?E. Mihály,?R. Panaccione,?E. Scherl,
文献类型：期刊论文
补充材料：只需要正文
作者：B. Sands,?P. Irving,?T. Hoops,?J. Izanec,?Long-Long Gao,?C. Gasink,?A. Greenspan,?M. Allez,?S. Danese,?S. Hanauer,?V. Jairath,?T. Kuehbacher,?J. Lewis,?E. Loftus,?E. Mihály,?R. Panaccione,?E. Scherl,
文献类型：期刊论文
补充材料：只需要正文
Elsevier
其它数据库
京公网安备 11010802042870号
